These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19236202)

  • 1. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress.
    Higashi Y
    Expert Opin Pharmacother; 2009 Feb; 10(2):323-31. PubMed ID: 19236202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases.
    Higashi Y; Jitsuiki D; Chayama K; Yoshizumi M
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):85-93. PubMed ID: 18221078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
    Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
    Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
    Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I
    J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury.
    Yoshida H; Yanai H; Namiki Y; Fukatsu-Sasaki K; Furutani N; Tada N
    CNS Drug Rev; 2006; 12(1):9-20. PubMed ID: 16834755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.
    Okamura K; Tsubokawa T; Johshita H; Miyazaki H; Shiokawa Y
    Neurol Res; 2014 Jan; 36(1):65-9. PubMed ID: 24074041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease.
    Kikuchi K; Tancharoen S; Takeshige N; Yoshitomi M; Morioka M; Murai Y; Tanaka E
    Int J Mol Sci; 2013 Jul; 14(7):13909-30. PubMed ID: 23880849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
    Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
    J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel antioxidant edaravone: from bench to bedside.
    Watanabe T; Tahara M; Todo S
    Cardiovasc Ther; 2008; 26(2):101-14. PubMed ID: 18485133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The free-radical scavenger, edaravone, augments NO release from vascular cells and platelets after laser-induced, acute endothelial injury in vivo.
    Yamashita T; Shoge M; Oda E; Yamamoto Y; Giddings JC; Kashiwagi S; Suematsu M; Yamamoto J
    Platelets; 2006 May; 17(3):201-6. PubMed ID: 16702048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.
    Zhang P; Li W; Li L; Wang N; Li X; Gao M; Zheng J; Lei S; Chen X; Lu H; Liu Y
    Neuroscience; 2012 Jan; 201():297-306. PubMed ID: 22116052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
    Tanaka M
    Nihon Yakurigaku Zasshi; 2002 May; 119(5):301-8. PubMed ID: 12061142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
    Wu HY; Tang Y; Gao LY; Sun WX; Hua Y; Yang SB; Zhang ZP; Liao GY; Zhou QG; Luo CX; Zhu DY
    Eur J Pharmacol; 2014 Oct; 740():522-31. PubMed ID: 24975100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic time window for ischemic stroke].
    Abe K
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1182-4. PubMed ID: 22277527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.
    Fujiwara N; Som AT; Pham LD; Lee BJ; Mandeville ET; Lo EH; Arai K
    Neurosci Lett; 2016 Oct; 633():7-13. PubMed ID: 27589890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils.
    Jin YJ; Mima T; Raicu V; Park KC; Shimizu K
    Neurosci Res; 2002 May; 43(1):75-9. PubMed ID: 12074843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
    Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters.
    Edaravone Acute Infarction Study Group
    Cerebrovasc Dis; 2003; 15(3):222-9. PubMed ID: 12715790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
    Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond neurological disease: new targets for edaravone (Review).
    Kikuchi K; Uchikado H; Miyagi N; Morimoto Y; Ito T; Tancharoen S; Miura N; Miyata K; Sakamoto R; Kikuchi C; Iida N; Shiomi N; Kuramoto T; Kawahara K
    Int J Mol Med; 2011 Dec; 28(6):899-906. PubMed ID: 21922128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.